Serotonin and disruptive behaviour; a critical evaluation of the clinical data

Human Psychopharmacology

Volumn 11, Issue 6, 1996, Pages 469-482

  Tuinier, S ^a   Verhoeven, W M A ^a   Van Praag, H M ^b  

^a VINCENT VAN GOGH INSTITUTE FOR PSYCHIATRY   (Netherlands)

^b MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

aggression; corticosteroids; CSF 5 HIAA; impulsivity; prolactin; serotonin

Indexed keywords

5 HYDROXYINDOLEACETIC ACID; CORTICOSTEROID; SEROTONIN;

AGGRESSION; ARTICLE; BEHAVIOR DISORDER; HUMAN; PERSONALITY DISORDER; PRIORITY JOURNAL; STRESS;

EID: 0030448186     PISSN: 08856222     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1099-1077(199611)11:6<469::AID-HUP817>3.0.CO;2-X     Document Type: Article

References (66)

1. Abbar, M., Courtet, P., Amadeo, S., Caer, Y., Mallet, J., Baldi-Moulinier, M., Castelnau, D. and Malafosse, A. (1995). Suicidal behavior and the tryptophan hydoxylase gene. Achives of General Psychiatry, 52, 846-849.
2. Antelman, S. M. and Chiodo, L. A. (1984). Stress: its effect on interactions among biogenic amines and role in the induction and treatment of disease. In: Handbook of Psychopharmacology, Iversen, L. L. and Snyder, S. H. (Eds), Plenum Press, New York, pp. 279-341.
3. Åsberg, M., Traskman, L. and Thorén, P. (1976). 5-HIAA in the cerebrospinal fluid: a biochemical suicide predictor. Archives of General Psychiatry, 33, 1193-1197.
4. Barratt, E. S. and Patton, J. H. (1983). Impulsivity: cognitive, behavioral, and psychophysiological correlates. In: Biological Bases of Sensation Seeking, Impulsivity, and Anxiety, Zuckerman, M. (Ed.), Lawrence Earlbaum Association, Hillsdale, New York, pp. 77-121.
5. Bertilsson, L. (1987). 5-Hydroxyindoleacetic acid in cerebrospinal fluid - methodological and clinical aspects. Life Sciences, 41, 821-824.
6. Bioulac, B., Benezech, M., Renoud, B., Roche, D. and Noël, B. (1978). Biogenic amines in 47XYY syndrome. Neuropsychobiology, 4, 366-370.
7. Botsis, A. J., Plutchik, R., Kotler, M. and Van Praag, H. M. (1995). Parental loss and family violence as correlates of suicide and violence risk. Suicide and Life-Threatening Behavior, 25, 253-260.
8. Brain, P. F. and Haug, M. (1992). Hormonal and neurochemical correlates of various forms of animal 'aggression'. Psychoneuroendocrinology, 17, 537-551.
9. Brown, G. L., Goodwin, F. K., Ballenger, J. C., Goyer, P. F. and Major, L. F. (1979). Aggression in humans correlates with cerebrospinal fluid amine metabolites. Psychiatry Research, 1, 131-139.
10. Brunner, H. G., Nelen, M., Breakefield, X. O., Ropers, H. H. and Van Oost, B. A. (1993b). Abnormal behavior associated with a point mutation in the structural gene for monoamine oxidase A. Science, 262, 578-580.
11. Brunner, H. G., Nelen, M. R., Van Zandvoort, P., Abeling, N. G. G. M., Van Gennip, A. H., Wolters, E. C., Kuiper, M. A., Ropers, H. H. and Van Oost, B. A. (1993a). X-linked borderline mental retardation with prominent behavioral disturbance: phenotype, genetic localization, and evidence for disturbed monoamine metabolism. American Journal of Human Genetics, 52, 1032-1039.
12. Buchsbaum, M. S., Murphy, D. L., Coursey, R. D., Lake, C. R. and Zeigler, M. G. (1978). Platelet monoamine oxidase, plasma dopamine-beta-hyroxylase and attention in a 'biochemical high risk' sample. Journal of Psychiatric Research, 14, 215-224.
13. Castellanos, X., Elia, J., Kruesi, M. J. P., Gulotta, C. S., Mefford, I. N., Potter, W. Z., Ritchie, G. F. and Rapoport, J. L. (1994). Cerebrospinal fluid monoamine metabolites in boys with attention-deficit hyperactivity disorder. Psychiatry Research, 52, 305-316.
14. Charney, D. S., Heninger, D. R., Reinhard, J. F., Sternberg, D. and Hafstead, K. M. (1982). The effect of i.v. 1-tryptophan on prolactin, growth hormone, and mood and healthy subjects. Psychopharmacology, 78, 38-43.
15. 1a receptor function in impulsive aggressive behavior in humans. Psychopharmacology Bulletin, 26, 393-405.
16. Coccaro, E. F., Siever, L. J., Klar, H. M., Maurer, G., Chochrane, K., Cooper, T. B., Mohs, R. C. and Davis, K. L. (1989). Serotonergic studies in patients with affective and personality disorders. Archives of General Psychiatry, 46, 587-599.
17. De Kloet, E. R. (1991). Brain corticosteroid receptor balance and homeostatic control. Frontiers in Neuroendocrinology, 12, 95-164.
18. Edmunds, G. and Kendrick, D. C. (1980). The Measurement of Human Aggressiveness. Ellis Horwood, Chichester.
19. Fishbein, D. H., Lozovsky, D. and Jaffe, J. H. (1989). Impulsivity, aggression, and neuroendocrine responses to serotonergic stimulation in substance abusers. Biological Psychiatry, 25, 1049-1066.
20. Gabel, S., Stadler, J., Bjorn, J., Shindledecker, R. and Bowden, C. (1993). Dopamine-beta-hydroxylase in behaviorally disturbed youth. Biological Psychiatry, 34, 434-442.
21. Galvin, M., Ten-Eyck, R., Shekhar, A., Stillwell, B., Fineberg, N., Laite, G. and Karwisch, G. (1995). Serum dopamine beta hydroxylase and maltreatment in psychiatrically hospitalized boys. Child Abuse and Neglect, 19, 821-832.
22. Golden, R. N., Gilmore, J. H., Corrigan, M. H. N., Ekstrom, R. D., Knight, B. T. and Garbutt, J. C. (1991). Serotonin, suicide, and aggression: clinical studies. Journal of Clinical Psychiatry, 52, S61-S69.
23. Halperin, J. M., Sharma, V., Siever, L. J., Schwartz, S. T., Matier, K., Wornell, G. and Newcorn, J. H. (1994). Serotonergic function in aggressive and non-agressive boys with attention deficit hyperactivity disorder. American Journal of Psychiatry, 151, 243-248.
24. Hathaway, S. and McKinley, J. (1983). MMPI: Manual for Administration and Scoring. University of Minnesota Press, Minneapolis, MN.
25. Invernizzi, R., Berettera, C., Garattini, S. and Samanin, R. (1986). d- and 1-Isomers of fenfluramine differ markedly in their interaction with brain serotonin and catecholamines in the rat. European Journal of Pharmacology, 120, 9-15.
26. Iqbal, N., Asnis, G. M., Wetzler, S., Kahn, R. S., Kay, S. R. and Van Praag, H. M. (1991). The MCPP challenge test in schizophrenia: hormonal and behavioral responses. Biological Psychiatry, 30, 770-778.
27. Kahn, R. S., Wetzler, S., Asnis, G. M., Suckow, R. F. and Van Praag, H. M. (1991). Pituitary hormone responses to meta-chlorophenylpiperazine in panic disorder and healthy control subjects. Psychiatry Research, 37, 25-34.
28. Lemus, C. Z. and Van Praag, H. M. (1986). Monoamine precursors: effects on neuroendocrine parameters. In: Handbook of Clinical Psychoneuroendocrinology. Nemeroff, C. B. and Loosen, P. (Eds), Guilford Press, New York.
29. Lester, D. (1995). The concentration of neurotransmitter metabolites in the cerebrospinal fluid of suicidal individuals: a meta-analysis. Pharmacopsychiatry, 28, 45-50.
30. Lucey, J. V., O'Keane, V., Butcher, G., Clare, A. W. and Dinan, T. G. (1992). Cortisol and prolactin responses to d-fenfluramine in non-depressed patients with obsessive-compulsive disorder: a comparison with depressed and healthy controls. British Journal of Psychiatry, 161, 517-521.
31. Mann, J. J., McBride, P. A., Malone, K. M., DeMeo, M. and Keilp, J. (1995). Blunted serotonergic responsivity in depressed inpatients. Neuropsychopharmacology, 13, 53-64.
32. Miczek, K. A., Weerts, E., Hanney, M. and Tidey, J. (1994). Neurobiological mechanisms controlling aggression: preclinical developments for pharmacotherapy interventions. Neuroscience and Biobehavioral Reviews, 18, 97-110.
33. Moeller, F. G., Steinberg, J. L., Petty, F., Fulton, M., Cherek, D. R., Kramer, G. and Garver, D. L. (1994). Serotonin and impulsive/aggressive behavior in cocaine dependent subjects. Progress in Neuropsychopharmacology and Biological Psychiatry, 18, 1027-1035.
34. Møller, S. E., Mortensen, E. L., Breum, L., Alling, C., Larsen, O. G., Boge-Rasmussen, T., Jensen, C. and Bennicke, K. (1996). Aggression and personality: association with amino acids and monoamine metabolites. Psychological Medicine, 26, 323-331.
35. Morell, V. (1993). Evidence found for a possible 'aggression gene'. Science, 260, 1722-1723.
36. Moss, H. B., Yao, J. K. and Panzak, G. L. (1990). Serotonergic responsivity and behavioral dimensions in antisocial personality disorder with substance abuse. Biological Psychiatry, 28, 325-338.
37. Nielsen, D. A., Goldman, D., Virkkunen, M., Tokola, R., Rawlings, R. and Linnoila, M. (1994). Suicidality and 5-hydroxyindoleacetic acid concentration associated with a tryptophan hydroxylase polymorphism. Archives of General Psychiatry, 51, 34-38.
38. O'Keane, V. and Dinan, T. G. (1991). Prolactin and cortisol responses to d-fenfluramine in major depression: evidence for diminished responsivity of central serotonergic function. American Journal of Psychiatry, 148, 1009-1015.
39. O'Keane, V., Moloney, E., O'Neill, H., O'Connor, A., Smith, C. and Dinan, T. G. (1992b). Blunted prolactin responses to d-fenfluramine in sociopathy evidence for subsensitivity of central serotonergic function. British Journal of Psychiatry, 160, 643-646.
40. O'Keane, V., McLoughlin, D. and Dinan, T. G. (1992a). d-Fenfluramine-induced prolactin and cortisol release in major depression: response to treatment. Journal of Affective Disorders, 26, 143-150.
41. Oxenstierna, G., Edman, G., Iselius, L., Oreland, L., Ross, S. B. and Sedvall, G. (1986). Concentrations of monoamine metabolites in the cerebrospinal fluid of twins and unrelated individuals - a genetic study. Journal of Psychiatry Research, 20, 19-29.
42. Paris, J. (1994). The etiology of borderline personality disorder: a biopsychosocial approach. Psychiatry, 57, 316-325.
43. Pedersen, N. L., Oreland, L., Reynolds, C. and McClearn, G. E. (1993). Importance of genetic effects for monoamine oxidase activity in thrombocytes in twins reared apart and twins reared together. Psychiatry Research, 46, 239-251.
44. Rogeness, G. A., Hernandez, J. M., Macedo, C. A., Amruns, S. A. and Hoppe, S. K. (1986). Near zero plasma dopamine-beta-hydroxylase and conduct disorder in emotionally disturbed boys. Journal of the American Academy of Child and Adolescent Psychiatry, 25, 1155-1158.
45. Rogeness, G. A., Hernandez, J. M., Macedo, C. A., Mitchell, E. L., Amrung, S. A. and Harris, W. R. (1984). Clinical characteristics of emotionally disturbed boys with very low activities of dopamine-beta-hydroxylase. Journal of the American Academy of Child and Adolescent Psychiatry, 23, 203-208.
46. Roy, A. and Linnoila, M. (1990). Monoamines and suicidal behavior. In: Violence and Suicidality, Van Praag, H. M., Plutchik, R. and Apter, A. (Eds), Brunner/Mazel Publishers, New York, pp. 141-183.
47. Siever, L. J., Coccaro, E. F., Zemishlany, Z., Silverman, J., Klar, H., Losonczy, M. F., Davidson, M., Friedman, R., Mohs, R. C. and Davis, K. L. (1987). Psychobiology of personality disorders: pharmacologic implications. Psychopharmacology Bulletin, 23, 333-336.
48. Smith, D. F. (1994). Type A personalities tend to have low platelet monoamine oxidase activity. Acta Psychiatrica Scandinavica, 89, 88-91.
49. Stein, D. J., Dodman, N. H., Borschelt, P. and Hollander, E. (1994). Behavioral disorders in veterinary practice: relevance to psychiatry. Comprehensive Psychiatry, 35, 275-285.
50. Stoff, D. M., Pasatiempo, A. P., Young, J., Cooper, T. B., Bridger, W. H. and Rabinovich, H. (1992). Neuroendocrine responses to challenge with d1-fenfluramine and aggression in disruptive behavior disorders of children and adolescents. Psychiatry Research, 43, 263-276.
51. Thompson, P. A., Maes, M. and Meltzer, H. Y. (1994). Effect of placebo control condition in neuroendocrine challenge studies. Psychiatry Research, 52, 317-326.
52. Tollefson, G. D. (1989). Serotonin and alcohol: interrelationships. Psychopathology, 22(Suppl. 1), 37-48.
53. Tuinier, S. and Verhoeven, W. M. A. (1995). Dimensional classification and behavioral pharmacology of personality disorders; a review and hypothesis. European Neuropsychopharmacology, 5, 135-146.
54. Tuinier, S., Verhoeven, W. M. A., Pepplinkhuizen, L., Scherders, M. J. W. T. and Fekkes, D. (1995a). Neuropsychiatric and biochemical characteristics of X-linked MAO-A deficiency syndrome. New Trends in Experimental and Clinical Psychiatry, 11, 99-107.
55. Tuinier, S., Verhoeven, W. M. A. and Van Praag, H. M. (1995b). CSF 5-HIAA and aggression, a critical reappraisal of the clinical data. International Clinical Psychopharmacology, 10, 147-156.
56. Van Praag, H. M. (1990). Two-tier diagnosing in psychiatry. Psychiatry Research, 34, 1-11.
57. Van Praag, H. M. (1993). Diagnosis, the rate-limited factor of biological depression research. Neuropsychobiology, 28, 197-206.
58. Van Praag, H. M. and Leijnse, B. (1965). Neubewertung des Syndroms. Skizze eine functionellen Pathologie. Psychiatrie, Neurologie und Neurochirurgie, 68, 50-66.
59. Van Praag, H. M., Asnis, G. M., Kahn, R. S., Brown, S. L., Korn, M., Harkavy Friedman, J. M. and Wetzler, S. (1990). Monoamines and abnormal behavior: A multiaminergic perspective. British Journal of Psychiatry, 157, 723-734.
60. Van Praag, H. M., Kahn, R. S., Asnis, G. M., Wetzler, S., Brown, S. L., Bleich, A. and Korn, M. L. (1987b). Denosologization of biological psychiatry or the specificity of 5-HT disturbances in psychiatric disorders. Journal of Affective Disorders, 13, 1-8.
61. Van Praag, H. M., Lemus, C. and Kahn, R. (1987a). Hormonal probes of central serotonergic activity: do they really exist? Biological Psychiatry, 22, 86-98.
62. Verhoeven, W. M. A. and Tuinier, S. (1993). Affective and aggressive behavioral disorders; thoughts about diagnosis and etiology. New Trends in Experimental and Clinical Psychiatry, 9, 123-136.
63. Virkkunen, M. and Linnoila, M. (1993). Brain serotonin, type II alcoholism and impulsive violence. Journal of Studies on Alcohol, Suppl. 11, 163-169.
64. Wetzler, S., Kahn, R. S., Asnis, G. M., Korn, M. and Van Praag, H. M. (1991). Serotonin receptor sensitivity and aggression. Psychiatry Research, 1, 271-279.
65. Yatham, L. N. and Steiner, M. (1993). Neuroendocrine probes of serotonergic function: a critical review. Life Sciences, 53, 447-463.
66. Young, W. F., Laws, E. R., Sharbrough, F. W. and Weinshilboum, R. M. (1986). Human monoamine oxidase. Archives of General Psychiatry, 3, 604-609.